Kynexis Alternatives & Competitors

12 companies similar to Kynexis — Kynexis is advancing the first potential precision medicine for the treatment of...

Afecta Pharmaceuticals

Creating Precision Medicines...More Efficiently

Irvine, United States

Health Care Health and Wellness +1

ProJenX

ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...

9 Series A $21.00M

New York, United States

Biopharma Biotechnology +2

Monument Therapeutics

Bringing Precision Medicine to Neuroscience Drug Development

6 Venture round $4.13M

Macclesfield, United King...

Biotechnology Health Care +1

Neumora

Pioneering a new era of medicines for brain diseases

111 Series B $612.00M

Watertown, United States

Biotechnology Health Care

Track all Kynexis competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cadent Therapeutics

Pioneering precision neuroscience to restore cognitive and motor function through groundbr...

Series B $66.65M

Biotechnology Health Care +2

GlycoEra AG

Advancing Glycan Mediated Therapy

30 Series B $179.00M

Wadenswil, Switzerland

Biotechnology Health Care

Ikena Oncology (Merged with ImageneBio)

Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...

14 Post-IPO Equity $209.00M

Boston, United States

Biotechnology Health Care +1

Lumos Pharma

Transforming Lives with Rare Focus

47 Series B $53.50M

Austin, United States

Biopharma Biotechnology +2

Xosomix

Next generation therapeutics based on exosomes

San Diego, United States

Health Care Health and Wellness

Ophidion

Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...

Convertible Note $1.70M

Biotechnology Health Care +1

Cajal Therapeutics

Cajal Therapeutics is a Seattle biotechnology company dedicated to developing innovative m...

38 Series A

Seattle, United States

Biotechnology Health and Wellness +1

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

54 Series D $300.00M

Chicago, United States

Biopharma Biotechnology +3

About Kynexis

Kynexis is a burgeoning startup founded in 2023, operating at the intersection of Biotechnology and Health Care. The company is leading a biomarker-driven approach to therapeutics, focusing on brain diseases. Its mission, captured succinctly in its slogan—“Kynexis is advancing the first potential precision medicine for...

Services

Development of precision therapeutics for brain diseases, Phase 1 and Phase 2 clinical trials, Use of biomarkers and human genetics in drug development

Target Customers

Individuals with cognitive impairment associated with schizophrenia, Healthcare providers treating neuropsychiatric disorders, Pharmaceutical companies seeking collaboration in CNS drug development

Business keywords

Precision Medicine, Cognitive Impairment, Schizophrenia Treatment, Biomarker-Based Approach, Brain Diseases, KAT-II Enzyme, Kynurenine Pathway, Small Molecule Therapeutics, First-in-Class Treatment, Neuroscience, Pharmaceutical Development, Patient Stratification, Data-Driven Medicine

Business Model

B2B, B2D

Revenue Model

Licensing, Product Sales

Frequently Asked Questions

Companies similar to Kynexis include Afecta Pharmaceuticals, ProJenX, Monument Therapeutics, Neumora, Cadent Therapeutics. They work in Biotechnology and Health Care and share Kynexis's focus on precision medicine, neuroscience and small molecule therapeutics.

Bounce Watch lists 12 companies that share Kynexis's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Kynexis and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Kynexis Profile Afecta Pharmaceuticals Alternatives ProJenX Alternatives Monument Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Kynexis on 28 Jan 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.